Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Tumor Progression02:07

Tumor Progression

7.1K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.1K
Tumor Immunotherapy01:27

Tumor Immunotherapy

1.4K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.4K
Cancer Survival Analysis01:21

Cancer Survival Analysis

560
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
560
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

6.2K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
6.2K
Classification of Leukocytes01:30

Classification of Leukocytes

4.5K
Leukocytes are classified into two groups based on the presence or absence of cytoplasmic granules. Granular leukocytes, which contain granules, belong to the myeloid lineage and are divided into three subtypes: neutrophils, eosinophils, and basophils. These cells are roughly spherical and characterized by the granules in their cytoplasm.
Neutrophils are the most abundant type of granular leukocytes, comprising 50-70% of all leukocytes. They feature small, evenly distributed granules and a...
4.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exploring Complex Genetic Mechanisms in Brain Imaging Genetics via a New Multi-task Learning Method.

IEEE transactions on computational biology and bioinformatics·2026
Same author

stDGCN: A dual-augmentation graph convolutional network for identifying spatial domains with attention mechanism.

IEEE journal of biomedical and health informatics·2026
Same author

SpaVGMC: A Unified Representation Learning Framework via Structural and Semantic Alignment in Spatial Transcriptomics.

Journal of chemical information and modeling·2026
Same author

MHNNMDA: multi-stage hypergraph neural network for predicting miRNA-disease association types.

Journal of computer-aided molecular design·2026
Same author

Prediction of multicategory miRNA-disease associations based on bidirectional hypergraph attention network and gated convolutional strategy.

Journal of computer-aided molecular design·2026
Same author

Two-Stage Multi-View Graph Spectral Clustering for Single-Cell RNA-Seq Data.

Current genomics·2026
Same journal

An interpretable framework for cancer drug response prediction using integrated drug and multi-omics data with a hybrid Bi-LSTM-GRU network.

Computational biology and chemistry·2026
Same journal

SegMWB: A lightweight deep learning framework for microscopic image classification.

Computational biology and chemistry·2026
Same journal

Protein dynamic simulations: From early inception to clinical translation over half a century.

Computational biology and chemistry·2026
Same journal

Integrated omics and virtual screening predict Tabularin as a dual inhibitor of the prognostic microRNAs mir-19a and mir-32 in colorectal cancer.

Computational biology and chemistry·2026
Same journal

In silico characterization of acetyl-CoA carboxylase from Staphylococcus aureus and Escherichia coli: A comparative analysis.

Computational biology and chemistry·2026
Same journal

An optimized cascaded transformer with progressive attention for lung and colon cancer diagnosis from histopathological images.

Computational biology and chemistry·2026
See all related articles

Related Experiment Video

Updated: Dec 9, 2025

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
07:15

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Published on: August 16, 2020

7.2K

L2,1-Extreme Learning Machine: An Efficient Robust Classifier for Tumor Classification.

Liang-Rui Ren1, Ying-Lian Gao2, Jin-Xing Liu1

  • 1School of Information Science and Engineering, Qufu Normal University, Rizhao, China.

Computational Biology and Chemistry
|September 12, 2020
PubMed
Summary
This summary is machine-generated.

A new L2,1-Extreme Learning Machine (L2,1-ELM) enhances robustness for high-dimensional cancer and single-cell RNA sequencing data classification. This method minimizes noise and outliers, showing great potential in cancer sample analysis.

Keywords:
Extreme Learning MachineL(2,1)-normRobustSingle-cell RNA SequencingSupervised Learning

More Related Videos

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.6K

Related Experiment Videos

Last Updated: Dec 9, 2025

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
07:15

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Published on: August 16, 2020

7.2K
Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.6K

Area of Science:

  • Bioinformatics
  • Machine Learning
  • Genomics

Background:

  • Cancer research generates vast gene expression and single-cell RNA sequencing (scRNA-seq) datasets.
  • Classifying high-dimensional biological data presents significant technical challenges.
  • Traditional Extreme Learning Machine (ELM) methods lack robustness against noise and outliers.

Purpose of the Study:

  • To propose a novel, robust Extreme Learning Machine (ELM) method for high-dimensional data classification.
  • To improve the robustness of ELM by introducing the L2,1-norm into the loss function.
  • To evaluate the efficacy of the proposed method on benchmark datasets and real-world cancer data.

Main Methods:

  • Development of the L2,1-Extreme Learning Machine (L2,1-ELM) by incorporating the L2,1-norm into the ELM loss function.
  • Evaluation of L2,1-ELM on five UCI benchmark datasets.
  • Application and validation of L2,1-ELM on The Cancer Genome Atlas (TCGA) and scRNA-seq datasets for cancer sample classification.

Main Results:

  • The proposed L2,1-ELM achieved competitive results on UCI datasets.
  • Experimental results on TCGA and scRNA-seq datasets demonstrated the method's effectiveness in cancer sample classification.
  • The L2,1-norm effectively minimized the influence of noise and outliers, enhancing classification robustness.

Conclusions:

  • The L2,1-Extreme Learning Machine (L2,1-ELM) offers a robust approach for classifying high-dimensional biological data.
  • The method shows significant potential for applications in cancer research, particularly in analyzing TCGA and scRNA-seq data.
  • ELM and its variants are promising tools for advancing cancer sample classification and analysis.